RateGain announced Uzbekistan Airways selected its AirGain fare-intelligence platform following a competitive tender. No contract value was disclosed in the press release.
Ansal Properties & Infrastructure intimated that its Board will meet on 18 Nov 2026 to approve Q1 FY27 standalone results. The meeting is scheduled and has not yet been held.
Wanbury received ANVISA (Brazil FDA) CADIFA approval for Metformin HCl EP grade API, its third consecutive ANVISA clearance. The company has initiated customer talks to increase API volumes in Brazil.
Pelatro's board approved allotment of 6,85,000 convertible warrants at ₹400 each, raising ₹27.40 Crore from promoters and public investors. Shareholders approved the issuance in October 2026.
Kothari Industrial confirmed the PAS-3 filing for its ₹45 crore share acquisition in associate PKFPL. The 4.5 crore shares at ₹10 each complete regulatory formalities.
PFL Infotech's Board approved unaudited standalone financial results for Q2 and H1 FY27. Revenue was nil with a net loss of ₹4.25 lakh for the half-year.
Infosys Science Foundation awarded six researchers the Infosys Prize 2026, totaling USD 600,000 in prize money. The foundation recognized early-career talent across six scientific disciplines.
Midwest Ltd filed its quarterly BSE shareholding pattern for the quarter ended 30 September 2026. The filing is routine SEBI Reg 31 disclosure with no transaction.
Smruthi Organics received the Brazilian GMP (CBPF) certificate for its Unit II API, Levamlodipine Besylate Hemi pentahydrate. This strengthens its regulatory presence in the Brazilian pharmaceutical market.
Boston Commerce Ltd scheduled its board meeting for 15 Nov 2026 to consider unaudited results for Q2 and Q1/H1 FY27. The trading window will remain closed until 48 hours after results declaration.
Ansal Properties informs exchanges of delay in Q2 FY27 results declaration due to pending Q1 finalization. No financial figures are reported in this filing.
Sai Life Sciences filed a Crisil monitoring agency report on IPO proceeds utilisation for the quarter ended 30 September 2026. It is a routine SEBI-mandated compliance certificate with no transaction or business event.
Ceat Ltd notified BSE and NSE about loss of 11 share certificates held by Ambalal Mohanlal Kayastha. The RTA NSDL issued a public notice seeking information on the whereabouts of the original certificates.
Lords Ishwar Hotels clarified that its GSM Stage 1 inclusion stems from routine exchange surveillance, not any material development. The company affirmed full LODR compliance.
KECL received BSE and NSE listing approvals for 34,68,007 preferential issue shares to Kirloskar Power Equipments Limited. The issue value is approximately ₹40 Crore.
Sigachi Industries filed its quarterly IPO-proceeds monitoring agency report for the quarter ended 30.09.2026. Kotak Mahindra Bank confirmed no deviation from the stated objects of the offer.
Avantel stated no undisclosed information explains the recent volume spurt in its shares. The company attributed the increase to purely market-driven trading activity.
Shakti Pumps confirmed no undisclosed material information behind its volume spurt. The company attributed the movement to market forces and affirmed timely Reg 30 compliance.
Creative Newtech signed a strategic brand license with AT&T Intellectual Property, LLC for technology infrastructure products across India and international markets. No specific deal value was disclosed.
Zydus Lifesciences completed its ₹9.38 Crore 50% subscription in JV Zydus Sunshine Lifesciences. The transaction with Sunshine Healthcare Lanka was fully executed on November 11, 2026.
Astec LifeSciences replied to a BSE volume-movement query confirming no undisclosed price-sensitive developments. The company affirmed full compliance with Listing and PIT Regulations.